Senestech, Inc. (NASDAQ:SNES – Get Free Report) major shareholder Glenbrook Capital Management bought 40,807 shares of the firm’s stock in a transaction that occurred on Tuesday, February 17th. The shares were acquired at an average cost of $2.29 per share, with a total value of $93,448.03. Following the purchase, the insider directly owned 659,117 shares of the company’s stock, valued at $1,509,377.93. This trade represents a 6.60% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this link. Major shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.
Glenbrook Capital Management also recently made the following trade(s):
- On Thursday, February 19th, Glenbrook Capital Management purchased 34,613 shares of Senestech stock. The stock was acquired at an average cost of $2.40 per share, for a total transaction of $83,071.20.
- On Wednesday, February 18th, Glenbrook Capital Management acquired 10,481 shares of Senestech stock. The shares were bought at an average cost of $2.29 per share, with a total value of $24,001.49.
- On Friday, February 13th, Glenbrook Capital Management acquired 15,390 shares of Senestech stock. The stock was bought at an average price of $1.89 per share, with a total value of $29,087.10.
- On Thursday, February 12th, Glenbrook Capital Management bought 7,956 shares of Senestech stock. The shares were bought at an average price of $1.72 per share, for a total transaction of $13,684.32.
- On Wednesday, February 11th, Glenbrook Capital Management bought 8,000 shares of Senestech stock. The shares were bought at an average cost of $1.73 per share, for a total transaction of $13,840.00.
- On Thursday, February 5th, Glenbrook Capital Management purchased 2,884 shares of Senestech stock. The stock was bought at an average cost of $1.77 per share, with a total value of $5,104.68.
- On Wednesday, February 4th, Glenbrook Capital Management acquired 5,685 shares of Senestech stock. The shares were bought at an average price of $1.82 per share, for a total transaction of $10,346.70.
- On Monday, February 2nd, Glenbrook Capital Management acquired 42,739 shares of Senestech stock. The shares were bought at an average cost of $1.98 per share, for a total transaction of $84,623.22.
- On Friday, January 30th, Glenbrook Capital Management bought 5,399 shares of Senestech stock. The stock was purchased at an average price of $1.87 per share, with a total value of $10,096.13.
Senestech Stock Performance
Shares of Senestech stock opened at $2.36 on Friday. The business has a 50-day simple moving average of $2.12 and a 200 day simple moving average of $3.31. Senestech, Inc. has a one year low of $1.30 and a one year high of $6.24. The company has a debt-to-equity ratio of 0.01, a current ratio of 15.75 and a quick ratio of 14.73. The firm has a market capitalization of $12.32 million, a price-to-earnings ratio of -0.65 and a beta of 0.21.
Analyst Upgrades and Downgrades
Check Out Our Latest Stock Analysis on Senestech
Institutional Trading of Senestech
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in SNES. Corsair Capital Management L.P. purchased a new position in shares of Senestech during the second quarter valued at approximately $255,000. Sabby Management LLC bought a new position in Senestech during the 3rd quarter valued at $313,000. Diversify Advisory Services LLC bought a new position in Senestech during the 4th quarter valued at $34,000. Jane Street Group LLC bought a new stake in shares of Senestech in the 4th quarter worth $32,000. Finally, Millennium Management LLC bought a new stake in shares of Senestech in the 3rd quarter worth $126,000. 5.19% of the stock is owned by institutional investors.
About Senestech
SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.
The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.
Read More
- Five stocks we like better than Senestech
- The gold chart Wall Street is terrified of…
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- New gold price target
Receive News & Ratings for Senestech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senestech and related companies with MarketBeat.com's FREE daily email newsletter.
